PMDA — authorised 24 May 2013
- Marketing authorisation holder: Sanofi K.K.
- Status: approved
PMDA authorised Adlyxin on 24 May 2013
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 24 May 2013.
Sanofi K.K. holds the Japanese marketing authorisation.